{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:32:27Z","timestamp":1789997547888,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["PIPF-2024\/SAL-GL-34310"],"award-info":[{"award-number":["PIPF-2024\/SAL-GL-34310"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CP19\/00104"],"award-info":[{"award-number":["CP19\/00104"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Open Respiratory Archives"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.opresp.2025.100507","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T05:30:07Z","timestamp":1761370207000},"page":"100507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Phage Therapy for Hospital-Acquired Respiratory Bacterial Infections: A Review"],"prefix":"10.1016","volume":"8","author":[{"given":"Maria-Carmen","family":"Mu\u00f1oz-Egea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alianet","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Garc\u00eda-Quintanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.opresp.2025.100507_bib0365","article-title":"Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studies","volume":"51","author":"Pe\u00f1alva","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.opresp.2025.100507_bib0370","unstructured":"https:\/\/www.msdmanuals.com\/professional [last accessed 8.5.25]."},{"key":"10.1016\/j.opresp.2025.100507_bib0375","doi-asserted-by":"crossref","first-page":"ofaa389","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.opresp.2025.100507_bib0380","doi-asserted-by":"crossref","first-page":"107372","DOI":"10.1016\/j.ijantimicag.2024.107372","article-title":"Access to phage therapy at Hospices Civils de Lyon in 2022: implementation of the PHAGEinLYON Clinic programme","volume":"64","author":"Ferry","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.opresp.2025.100507_bib0385","unstructured":"https:\/\/www.who.int\/publications\/i\/item\/9789240093461 [last accessed 8.5.25]."},{"key":"10.1016\/j.opresp.2025.100507_bib0390","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/antibiotics10080946","article-title":"Successful intratracheal treatment of phage and antibiotic combination therapy of a multi-drug resistant Pseudomonas aeruginosa murine model","volume":"10","author":"Duplessis","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.opresp.2025.100507_bib0395","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1111\/bph.15526","article-title":"Inhaled bacteriophage therapy in a porcine model of pneumonia caused by Pseudomonas aeruginosa during mechanical ventilation","volume":"178","author":"Guillon","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.opresp.2025.100507_bib0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110825","article-title":"Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy","volume":"39","author":"Delattre","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.opresp.2025.100507_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307079","article-title":"Bacteriophages isolated from mouse feces attenuates pneumonia mice caused by Pseudomonas aeruginosa","volume":"19","author":"Sutnu","year":"2024","journal-title":"PLOS ONE"},{"key":"10.1016\/j.opresp.2025.100507_bib0410","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2020.11.019","article-title":"Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model","volume":"158","author":"Lin","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.opresp.2025.100507_bib0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115793","article-title":"Novel intranasal phage-CaEDTA-ceftazidime\/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection","volume":"168","author":"Shein","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.opresp.2025.100507_bib0420","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cmi.2022.01.006","article-title":"The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice","volume":"28","author":"Chang","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.opresp.2025.100507_bib0425","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01470-20","article-title":"Pharmacokinetics and time-kill study of inhaled antipseudomonal bacteriophage therapy in mice","volume":"65","author":"Chow","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.opresp.2025.100507_bib0430","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80326-0","article-title":"Using X-ray velocimetry to measure lung function and assess the efficacy of a Pseudomonas aeruginosa bacteriophage therapy for cystic fibrosis","volume":"14","author":"Harker","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.opresp.2025.100507_bib0435","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1517\/14656566.2012.729820","article-title":"Therapeutic options for Acinetobacter baumannii infections: an update","volume":"13","author":"Vila","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.opresp.2025.100507_bib0440","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.csbj.2022.12.045","article-title":"Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii","volume":"21","author":"Kabic","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.opresp.2025.100507_bib0445","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijantimicag.2012.09.005","article-title":"The emergence of clinical resistance to tigecycline","volume":"41","author":"Sun","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.opresp.2025.100507_bib0450","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.631585","article-title":"Clinical experience of personalized phage therapy against carbapenem-resistant Acinetobacter baumannii lung Infection in a patient with chronic obstructive pulmonary disease","volume":"11","author":"Tan","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0455","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/22221751.2021.1902754","article-title":"Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients","volume":"10","author":"Wu","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.opresp.2025.100507_bib0460","series-title":"Medical microbiology","author":"Murray","year":"2020"},{"key":"10.1016\/j.opresp.2025.100507_bib0465","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.831770","article-title":"Prolonged outbreak of carbapenem and colistin-resistant Klebsiella pneumoniae at a large tertiary Hospital in Brazil","volume":"13","author":"Rocha","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0470","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1017\/ice.2015.118","article-title":"Residence in skilled nursing facilities is associated with tigecycline nonsusceptibility in carbapenem-resistant Klebsiella pneumoniae","volume":"36","author":"van Duin","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0475","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/antibiotics9050232","article-title":"Bacteriophage therapy for critical infections related to cardiothoracic surgery","volume":"9","author":"Rubalskii","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.opresp.2025.100507_bib0480","doi-asserted-by":"crossref","first-page":"1601.e1","DOI":"10.1016\/j.cmi.2023.08.022","article-title":"Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy","volume":"29","author":"Li","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.opresp.2025.100507_bib0485","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00019-18","article-title":"Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis","volume":"31","author":"Parkins","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.opresp.2025.100507_bib0490","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/v13101901","article-title":"Phage therapy experience at the Eliava Phage Therapy Center: three cases of bacterial persistence","volume":"13","author":"Zaldastanishvili","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.opresp.2025.100507_bib0495","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5582\/bst.2022.01147","article-title":"Bacteriophage therapy for empyema caused by carbapenem-resistant Pseudomonas aeruginosa","volume":"16","author":"Chen","year":"2022","journal-title":"Biosci Trends"},{"key":"10.1016\/j.opresp.2025.100507_bib0500","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1751-7915.14217","article-title":"First-in-human application of double-stranded RNA bacteriophage in the treatment of pulmonary Pseudomonas aeruginosa infection","volume":"16","author":"Li","year":"2023","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.opresp.2025.100507_bib0505","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/jiac368","article-title":"Development of host immune response to bacteriophage in a lung transplant recipient on adjunctive phage therapy for a multidrug-resistant pneumonia","volume":"227","author":"Dan","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.opresp.2025.100507_bib0510","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.2147\/IDR.S413900","article-title":"Refractory Pseudomonas aeruginosa bronchopulmonary infection after lung transplantation for common variable immunodeficiency despite maximal treatment including IgM\/IgA-enriched immunoglobulins and bacteriophage therapy","volume":"16","author":"Lev\u00eaque","year":"2023","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.opresp.2025.100507_bib0515","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1038\/s41467-023-39370-z","article-title":"Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa","volume":"14","author":"K\u00f6hler","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.opresp.2025.100507_bib0520","article-title":"Bacteriophage therapy for pan-drug-resistant Pseudomonas aeruginosa in two persons with cystic fibrosis","volume":"11","author":"Hahn","year":"2023","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.opresp.2025.100507_bib0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199442","article-title":"Safety and tolerability of bronchoscopic and nebulised administration of bacteriophage","volume":"348","author":"Singh","year":"2024","journal-title":"Virus Res"},{"key":"10.1016\/j.opresp.2025.100507_bib0530","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","article-title":"Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis","volume":"31","author":"Chan","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.opresp.2025.100507_bib0535","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/antibiotics10081000","article-title":"Gram-positive pneumonia: possibilities offered by phage therapy","volume":"10","author":"Fern\u00e1ndez","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.opresp.2025.100507_bib0540","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.medj.2024.05.017","article-title":"Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients","volume":"5","author":"Bernab\u00e9u-Gimeno","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.opresp.2025.100507_bib0545","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/antibiotics11101322","article-title":"Alternatives to antibiotics against Mycobacterium abscessus","volume":"11","author":"Broncano-Lavado","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.opresp.2025.100507_bib0550","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41591-021-01403-9","article-title":"Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection","volume":"27","author":"Dedrick","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.opresp.2025.100507_bib0555","doi-asserted-by":"crossref","first-page":"ofac194","DOI":"10.1093\/ofid\/ofac194","article-title":"Nebulized bacteriophage in a patient with refractory Mycobacterium abscessus lung disease","volume":"9","author":"Dedrick","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.opresp.2025.100507_bib0560","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciac453","article-title":"Phage therapy of Mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease","volume":"76","author":"Dedrick","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.opresp.2025.100507_bib0565","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.cell.2022.04.024","article-title":"Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection","volume":"185","author":"Nick","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.opresp.2025.100507_bib0570","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54666-4","article-title":"Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infection","volume":"15","author":"Cristinziano","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.opresp.2025.100507_bib0575","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2451048","article-title":"Exploration of the feasibility of clinical application of phage treatment for multidrug-resistant Serratia marcescens -induced pulmonary infection","volume":"14","author":"Duan","year":"2025","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.opresp.2025.100507_bib0580","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/ph18081115","article-title":"Bacteriophage therapy: discovery, development, and FDA approval pathways","volume":"18","author":"Niazi","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.opresp.2025.100507_bib0585","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1286046","article-title":"Molecular studies of phages-Klebsiella pneumoniae in mucoid environment: innovative use of mucolytic agents prior to the administration of lytic phages","volume":"14","author":"Pacios","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0590","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/antibiotics14060545","article-title":"The current landscape of phage-antibiotic synergistic (PAS) interactions","volume":"14","author":"Supina","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.opresp.2025.100507_bib0595","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/v14010033","article-title":"Preclinical assessment of bacteriophage therapy against experimental Acinetobacter baumannii lung infection","volume":"14","author":"Wienhold","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.opresp.2025.100507_bib0600","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00253-024-13208-0","article-title":"A novel Saclayvirus Acinetobacter baumannii phage genomic analysis and effectiveness in preventing pneumonia","volume":"108","author":"Li","year":"2024","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.opresp.2025.100507_bib0605","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00467-24","article-title":"In vivo efficacy of phage cocktails against carbapenem resistance Acinetobacter baumannii in the rat pneumonia model","volume":"98","author":"Li","year":"2024","journal-title":"J Virol"},{"key":"10.1016\/j.opresp.2025.100507_bib0610","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00379-19","article-title":"Phage therapy of pneumonia is not associated with an overstimulation of the inflammatory response compared to antibiotic treatment in mice","volume":"63","author":"Dufour","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.opresp.2025.100507_bib0615","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1007\/s00284-020-02041-z","article-title":"Potential of a bacteriophage isolated from wastewater in treatment of lobar pneumonia infection induced by Klebsiella pneumoniae in mice","volume":"77","author":"Soleimani Sasani","year":"2020","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0620","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jgar.2019.09.018","article-title":"Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model","volume":"21","author":"Anand","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.opresp.2025.100507_bib0625","article-title":"Combination therapy of phage vB_KpnM_P-KP2 and gentamicin combats acute pneumonia caused by K47 serotype Klebsiella pneumoniae","volume":"12","author":"Wang","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0630","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13568-021-01181-0","article-title":"Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model","volume":"11","author":"Sundaramoorthy","year":"2021","journal-title":"AMB Express"},{"key":"10.1016\/j.opresp.2025.100507_bib0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245354","article-title":"Klebsiella virus UPM2146 lyses multiple drug-resistant Klebsiella pneumoniae in vitro and in vivo","volume":"16","author":"Assafiri","year":"2021","journal-title":"PLOS ONE"},{"key":"10.1016\/j.opresp.2025.100507_bib0640","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.950737","article-title":"Genomic characterization of a new phage BUCT541 against Klebsiella pneumoniae K1-ST23 and efficacy assessment in mouse and Galleria mellonella larvae","volume":"13","author":"Pu","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0645","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02358-22","article-title":"Bacteriophage effectively rescues pneumonia caused by prevalent multidrug-resistant Klebsiella pneumoniae in the early stage","volume":"10","author":"Gan","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.opresp.2025.100507_bib0650","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1265011","article-title":"Isolation and characterization of three novel lytic phages against K54 serotype carbapenem-resistant hypervirulent Klebsiella pneumoniae","volume":"13","author":"Fang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121639","article-title":"Characterization and genomic analysis of novel bacteriophage NK20 to revert colistin resistance and combat pandrug-resistant Klebsiella pneumoniae in a rat respiratory infection model","volume":"322","author":"Al-Madboly","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.opresp.2025.100507_bib0660","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.3390\/ijms25179595","article-title":"In vitro and in vivo assessments of newly isolated N4-like Bacteriophage against ST45 K62 capsular-type Carbapenem-resistant Klebsiella pneumoniae: vB_kpnP_KPYAP-1","volume":"25","author":"Natarajan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.opresp.2025.100507_bib0665","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12866-025-03851-6","article-title":"Potential of a phage cocktail in the treatment of multidrug-resistant Klebsiella pneumoniae pulmonary infection in mice","volume":"25","author":"Gou","year":"2025","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0670","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049159","article-title":"Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus","volume":"14","author":"Johansen","year":"2021","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.opresp.2025.100507_bib0675","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01832-20","article-title":"Novel lytic phages protect cells and mice against Pseudomonas aeruginosa infection","volume":"95","author":"Chen","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.opresp.2025.100507_bib0680","article-title":"The efficacy of phage therapy in a murine model of Pseudomonas aeruginosa pneumonia and sepsis","volume":"12","author":"Yang","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.opresp.2025.100507_bib0685","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.2147\/IDR.S326230","article-title":"Evaluation of phage therapy for pulmonary infection of mouse by liquid aerosol-exposure Pseudomonas aeruginosa","volume":"14","author":"Zhang","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.opresp.2025.100507_bib0690","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/v15020387","article-title":"Repetitive exposure to bacteriophage cocktails against Pseudomonas aeruginosa or Escherichia coli provokes marginal humoral immunity in na\u00efve mice","volume":"15","author":"Weissfuss","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.opresp.2025.100507_bib0695","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01781-24","article-title":"Effects of the combination of anti-PcrV antibody and bacteriophage therapy in a mouse model of Pseudomonas aeruginosa pneumonia","volume":"12","author":"Junya","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.opresp.2025.100507_bib0700","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/CCM.0000000000004352","article-title":"Nebulized bacteriophages for prophylaxis of experimental Ventilator-Associated Pneumonia due to methicillin-resistant Staphylococcus aureus","volume":"48","author":"Prazak","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.opresp.2025.100507_bib0705","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/v11010088","article-title":"Design and preclinical development of a phage product for the treatment of antibiotic-resistant Staphylococcus aureus infections","volume":"11","author":"Lehman","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.opresp.2025.100507_bib0710","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/infdis\/jiab112","article-title":"Benefits of aerosolized phages for the treatment of pneumonia due to methicillin-resistant Staphylococcus aureus: an experimental study in rats","volume":"225","author":"Prazak","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.opresp.2025.100507_bib0715","first-page":"435","article-title":"Experimental phage therapy against haematogenous multi-drug resistant Staphylococcus aureus pneumonia in mice","volume":"5","author":"Oduor","year":"2016","journal-title":"Afr J Lab Med"},{"key":"10.1016\/j.opresp.2025.100507_bib0720","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1164\/rccm.201812-2372OC","article-title":"Bacteriophages improve outcomes in experimental Staphylococcus aureus ventilator-associated Pneumonia","volume":"200","author":"Prazak","year":"2019","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Open Respiratory Archives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663625001316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663625001316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:50:31Z","timestamp":1789199431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2659663625001316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2659663625001316"],"URL":"https:\/\/doi.org\/10.1016\/j.opresp.2025.100507","relation":{},"ISSN":["2659-6636"],"issn-type":[{"value":"2659-6636","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phage Therapy for Hospital-Acquired Respiratory Bacterial Infections: A Review","name":"articletitle","label":"Article Title"},{"value":"Open Respiratory Archives","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.opresp.2025.100507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100507"}}